Chargement en cours...
New approaches in the management of advanced breast cancer – role of combination treatment with liposomal doxorubicin
Metastatic breast cancer (MBC) remains a major cause of morbidity and mortality in women worldwide. For three decades doxorubicin, alone or in combination with other cytotoxic agents, has been a mainstay of systemic therapy for MBC. However, its use is limited by cumulative cardiotoxicity. More rece...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3846637/ https://ncbi.nlm.nih.gov/pubmed/24367159 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|